Investigating the role of system xc- in glutamate, glutathione and synapse homeostasis in vivo
研究系统 xc- 在体内谷氨酸、谷胱甘肽和突触稳态中的作用
基本信息
- 批准号:10116499
- 负责人:
- 金额:$ 34.91万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-03-01 至 2023-02-28
- 项目状态:已结题
- 来源:
- 关键词:AMPA ReceptorsAcetylcysteineAcuteAddressAffectAmino AcidsAntioxidantsAstrocytesBiological ModelsBrainBrain DiseasesChronicComplementCouplesCysteineCystineDataDendritic SpinesDiseaseDoseElectroencephalogramEpilepsyEquilibriumExhibitsExonsGlutamate ReceptorGlutamatesGlutathioneGlutathione DisulfideHigh Pressure Liquid ChromatographyHippocampus (Brain)HomeostasisImmunohistochemistryIndividualKainic AcidKnockout MiceKnowledgeLightMaintenanceMeasurementMediatingMolecularMorphologyMusMutationNeuraxisNeuronsNeurotransmittersOxidation-ReductionPentylenetetrazolePharmacologyPhenotypePhysiologicalProcessPumpRegulationRoleSignal TransductionSourceSpecificityStrokeSulfhydryl CompoundsSynapsesSystemTestingTimeTraumatic Brain InjuryVertebral columnWestern Blottingantiporterbrain electrical activitybrain tissueconditional knockoutdesignelectrical measurementexperimental studyextracellularin vivointerestnervous system disorderneuronal excitabilitynew therapeutic targetreceptorreceptor expressionresponsescale upsensor technologystemtherapeutic targettransmission process
项目摘要
PROJECT SUMMARY
In several brain disorders including epilepsy, stroke and traumatic brain injury, an imbalance between the
excitatory and inhibitory (E/I) neurotransmitter systems exists. Understanding fully the cellular and molecular
processes that underlie normal, physiological transmission is the first step in determining how aberrations of
such might be countered to provide such individuals with E/I imbalance symptomatic relief. Recent evidence
from our lab demonstrates a role for the cystine/glutamate antiporter System xc- (Sxc-) ─ which exports glutamate
and imports cystine, the latter of which is the rate-limiting substrate for the synthesis of the thiol antioxidant
glutathione ─ in maintenance of E/I balance. Specifically, we find that sut/sut mice, which harbor a natural
mutation in SLC7a11 (SLC7a11sut/sut) and are therefore devoid of Sxc-, are considerably more hyperexcitable
than their wild-type littermates upon acute challenge with kainic acid or pentylenetetrazole. Paradoxically, after
repeated sub-acute/sub-chronic administration of the same chemoconvulsants, SLC7a11sut/sut mice exhibit signs
of hypoexcitability, a response polar opposite to that which occurs in wild-type littermate controls. The idea that
these paradoxical findings may result from the same underlying mechanism ─ namely synaptic scaling ─ will be
explored in this proposal. State-of-the-art in vivo sensor technology, as well as, cellular, molecular and
pharmacological approaches will be used to test the hypothesis that chronic loss of Sxc- leads to a scaling up of
glutamate receptors under basal conditions, whereas scaling down occurs under conditions of enhanced
neuronal activity ─ both in efforts to stabilize neuronal firing. Whether these finding are mediated by changes in
glutamate and/or glutathione will also be explored. Studies to determine the cellular specificity of response, with
specific focus on the role of the astrocyte, are also planned. Overall, these studies are designed to increase our
mechanistic understanding of the contribution of astrocyte Sxc- to glutamate, glutathione and activity homeostasis
in in vivo brain. More broadly, these efforts complement other ongoing efforts to identify targets to treat the E/I
imbalance that exists in many neurological disorders.
项目摘要
在几种脑部疾病中,包括癫痫,中风和创伤性脑损伤,
存在兴奋性和抑制性(E/I)神经递质系统。完全了解细胞和分子
基于正常,物理传播的过程是确定畸变的第一步
可能会反对这样的人,以使此类人有E/I不平衡的症状缓解。最近的证据
从我们的实验室中展示了胱氨酸/谷氨酸抗植物系统XC-(SXC-)的作用,该系统导出了谷氨酸
并进口胱氨酸,后者是硫醇抗氧化剂合成的速率限制底物
谷胱甘肽─维持E/I平衡。具体来说,我们发现有天然的SUT/SUT小鼠
SLC7A11(SLC7A11SUT/SUT)中的突变,因此没有SXC-,更为过度过度脱离
在用海藻酸或甲状腺乙酸甲酸甲酸酯急性挑战时,其野生型同窝窝倍植物。矛盾的是,之后
重复的亚急性/亚chronic给药相同的化学弹力,SLC7A11SUT/SUT小鼠暴露了迹象
在野生型窝窝对照中发生的反应性不足,与发生的反应相反。这个想法
这些自相矛盾的发现可能是由相同的基本机制造成的─即突触缩放级 - 将是
在此提案中探索。最先进的体内传感器技术以及细胞,分子和
药理学方法将用于检验以下假设,即慢性损失SXC会导致扩展
谷氨酸受体在基本条件下,而在增强的条件下进行缩小
神经元活性 - 均用于稳定神经元解击。这些发现是否是由变化介导的
还将探索谷氨酸和/或谷胱甘肽。研究以确定反应的细胞特异性,并
还计划了对星形胶质细胞的作用的特定关注。总体而言,这些研究旨在增加我们的
对星形胶质细胞SXC-对谷氨酸,谷胱甘肽和活动稳态的贡献的机械理解
体内大脑。从更广泛的角度来看,这些努力完成了其他持续的努力,以确定对待E/I的目标
在许多神经系统疾病中存在不平衡。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
SANDRA J HEWETT其他文献
SANDRA J HEWETT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('SANDRA J HEWETT', 18)}}的其他基金
Investigating the role of system xc- in glutamate, glutathione and synapse homeostasis in vivo
研究系统 xc- 在体内谷氨酸、谷胱甘肽和突触稳态中的作用
- 批准号:
10214720 - 财政年份:2020
- 资助金额:
$ 34.91万 - 项目类别:
Investigating the role of system xc- in glutamate, glutathione and synapse homeostasis in vivo
研究系统 xc- 在体内谷氨酸、谷胱甘肽和突触稳态中的作用
- 批准号:
10357770 - 财政年份:2018
- 资助金额:
$ 34.91万 - 项目类别:
Constructing a Conditional Slc7a11 (xCT) Null Mouse
构建条件 Slc7a11 (xCT) 空鼠标
- 批准号:
8302237 - 财政年份:2011
- 资助金额:
$ 34.91万 - 项目类别:
Constructing a Conditional Slc7a11 (xCT) Null Mouse
构建条件 Slc7a11 (xCT) 空鼠标
- 批准号:
8203292 - 财政年份:2011
- 资助金额:
$ 34.91万 - 项目类别:
相似国自然基金
乙酰半胱氨酸通过PI3K/AKT/mTOR通路增强CAR-CIK的抗肿瘤作用和机制研究
- 批准号:82303762
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
N-乙酰半胱氨酸介导线粒体SIRT3活化促进老年骨质疏松性骨修复的机制研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
N-乙酰半胱氨酸调控山羊繁殖机能的分子机制研究
- 批准号:
- 批准年份:2020
- 资助金额:36 万元
- 项目类别:地区科学基金项目
N-乙酰半胱氨酸介导成骨细胞circRNA_003251表达促进骨修复的机制研究
- 批准号:82072442
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
N-乙酰半胱氨酸通过DKK1甲基化激活Wnt/β-catenin信号通路促进骨修复的机制研究
- 批准号:81772358
- 批准年份:2017
- 资助金额:56.0 万元
- 项目类别:面上项目
相似海外基金
N-ACETYLCYSTEINE IN TREATMENT OF ACUTE LIVER FAILURE NOT CAUSE BY ACETAMINOPHEN
N-乙酰半胱氨酸治疗非对乙酰氨基酚引起的急性肝衰竭
- 批准号:
7605100 - 财政年份:2007
- 资助金额:
$ 34.91万 - 项目类别:
N-ACETYLCYSTEINE IN TREATMENT OF ACUTE LIVER FAILURE NOT CAUSE BY ACETAMINOPHEN
N-乙酰半胱氨酸治疗非对乙酰氨基酚引起的急性肝衰竭
- 批准号:
7374386 - 财政年份:2006
- 资助金额:
$ 34.91万 - 项目类别:
N-ACETYLCYSTEINE IN THE TREATMENT OF ACUTE LIVER FAILURE IN ADULTS
N-乙酰半胱氨酸治疗成人急性肝衰竭
- 批准号:
7374202 - 财政年份:2006
- 资助金额:
$ 34.91万 - 项目类别:
N-ACETYLCYSTEINE IN TREATMENT OF ACUTE LIVER FAILURE NOT CAUSE BY ACETAMINPHEN
N-乙酰半胱氨酸治疗非乙酰氨基酚引起的急性肝衰竭
- 批准号:
7202452 - 财政年份:2005
- 资助金额:
$ 34.91万 - 项目类别:
N-ACETYLCYSTEINE IN THE TREATMENT OF ACUTE LIVER FAILURE IN ADULTS
N-乙酰半胱氨酸治疗成人急性肝衰竭
- 批准号:
7205664 - 财政年份:2003
- 资助金额:
$ 34.91万 - 项目类别: